DyNAbind and OMass Announce Collaboration Agreement

We’re proud to announce our drug discovery collaboration with OMass Therapeutics! Check out our press release below, and don’t hesitate to get in touch with us to see how DyNAbind’s proprietary DNA-Encoded Library technologies offer a better path to higher-quality, more relevant medicinal chemistry starting points, even for classically challenging targets!